Paper35108564
Biophysical Characterization of Tolerogenic Lipid-Based Nanoparticles Containing Phosphatidylcholine and Lysophosphatidylserine.
Nguyen NH and 3 others. J Pharm Sci, 2022. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Biophysical Characterization of Tolerogenic Lipid-Based Nanoparticles Containing Phosphatidylcholine and Lysophosphatidylserine. Papers, record 35108564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35108564
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biophysical Characterization of Tolerogenic Lipid-Based Nanoparticles Containing Phosphatidylcholine and Lysophosphatidylserine.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nanoparticles | Major topic |
| Phosphatidylcholines | Major topic |
| Lecithins | |
| Lysophospholipids | |
| Organic Chemicals | |
| Phosphatidylserines |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI169296 | NIAID NIH HHS | United States | R01AI169296 | PubMed | NIH RePORTER |
| R01 HL070227 | NHLBI NIH HHS | United States | R01HL070227 | PubMed and NIH | NIH RePORTER |
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27148688 | Clusterin facilitates apoptotic cell clearance and prevents apoptotic cell-induced autoimmune responses. | Cell Death Dis | 2016 | https://conductscience.org/library/papers/27148688 | PubMed |
| 2 | 27379516 | Activation-Induced TIM-4 Expression Identifies Differential Responsiveness of Intestinal CD103+ CD11b+ Dendritic Cells to a Mucosal Adjuvant. | PLoS One | 2016 | https://conductscience.org/library/papers/27379516 | PubMed |
| 3 | 9832152 | Fatty acid composition of human brain phospholipids during normal development. | J Neurochem | 1998 | https://conductscience.org/library/papers/9832152 | PubMed |
| 4 | 25470136 | Novel insights into Tim-4 function in autoimmune diseases. | Autoimmunity | 2015 | https://conductscience.org/library/papers/25470136 | PubMed |
| 5 | 22215009 | Application of a mouse ligated Peyer’s patch intestinal loop assay to evaluate bacterial uptake by M cells. | J Vis Exp | 2011 | https://conductscience.org/library/papers/22215009 | PubMed |
| 6 | 25906908 | From zero to six double bonds: phospholipid unsaturation and organelle function. | Trends Cell Biol | 2015 | https://conductscience.org/library/papers/25906908 | PubMed |
| 7 | 17760435 | Effect of double bond position on lipid bilayer properties: insight through atomistic simulations. | J Phys Chem B | 2007 | https://conductscience.org/library/papers/17760435 | PubMed |
| 8 | 30599169 | Immunogenicity of Protein Pharmaceuticals. | J Pharm Sci | 2019 | https://conductscience.org/library/papers/30599169 | PubMed |
| 9 | 23149665 | TIM-4, expressed by medullary macrophages, regulates respiratory tolerance by mediating phagocytosis of antigen-specific T cells. | Mucosal Immunol | 2013 | https://conductscience.org/library/papers/23149665 | PubMed |
| 10 | 9569189 | Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation. | Thromb Haemost | 1998 | https://conductscience.org/library/papers/9569189 | PubMed |
| 11 | 7541795 | The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7541795 | PubMed |
| 12 | 27488899 | Phosphatidylserine Converts Immunogenic Recombinant Human Acid Alpha-Glucosidase to a Tolerogenic Form in a Mouse Model of Pompe Disease. | J Pharm Sci | 2016 | https://conductscience.org/library/papers/27488899 | PubMed |
| 13 | 18299615 | Use of fluorescence to determine the effects of cholesterol on lipid behavior in sphingomyelin liposomes and erythrocyte membranes. | J Lipid Res | 2008 | https://conductscience.org/library/papers/18299615 | PubMed |
| 14 | 29649469 | Phosphatidylserine Is Not Just a Cleanup Crew but Also a Well-Meaning Teacher. | J Pharm Sci | 2018 | https://conductscience.org/library/papers/29649469 | PubMed |
| 15 | 11554592 | Factor VIII inhibitors. | Adv Exp Med Biol | 2001 | https://conductscience.org/library/papers/11554592 | PubMed |
| 16 | 7014501 | Cell death: the significance of apoptosis. | Int Rev Cytol | 1980 | https://conductscience.org/library/papers/7014501 | PubMed |
| 17 | 29789388 | Tissue-resident macrophages in the intestine are long lived and defined by Tim-4 and CD4 expression. | J Exp Med | 2018 | https://conductscience.org/library/papers/29789388 | PubMed |
| 18 | 182064 | Thermotropic transitions in biomembranes. | Annu Rev Biophys Bioeng | 1976 | https://conductscience.org/library/papers/182064 | PubMed |
| 19 | 5637431 | Positional distribution of fatty acids in glycerophosphatides of bovine gray matter. | J Lipid Res | 1968 | https://conductscience.org/library/papers/5637431 | PubMed |
| 20 | 4324203 | Inside-outside transitions of phospholipids in vesicle membranes. | Biochemistry | 1971 | https://conductscience.org/library/papers/4324203 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42402311 | Immune tolerance platforms to mitigate unwanted immune responses. | J Pharm Sci | 2026 | https://conductscience.org/library/papers/42402311 | PubMed |
| 41972628 | Intestinal Microfold Cells Play a Critical Role in the Uptake and Oral Tolerance Mediated by Lysophosphatidylserine-Containing Lipidic Nanoparticles. | Nanomaterials (Basel) | 2026 | https://conductscience.org/library/papers/41972628 | PubMed |
| 41893804 | How to Employ Trained Immunity and Trained Immunity-Based Vaccines to Inhibit Allergic Inflammation. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41893804 | PubMed |
| 41390593 | Phosphatidylserine exposure on tolerogenic nanoparticle correlate with oral tolerance. | Sci Rep | 2025 | https://conductscience.org/library/papers/41390593 | PubMed |
| 38789479 | Comparison of the transcriptome, lipidome, and c-di-GMP production between BCGΔBCG1419c and BCG, with Mincle- and Myd88-dependent induction of proinflammatory cytokines in murine macrophages. | Sci Rep | 2024 | https://conductscience.org/library/papers/38789479 | PubMed |
| 36938103 | Delivery route considerations for designing antigen-specific biomaterial strategies to combat autoimmunity. | Adv Nanobiomed Res | 2023 | https://conductscience.org/library/papers/36938103 | PubMed |
| 36586393 | Phosphatidylserine-mediated oral tolerance. | Cell Immunol | 2023 | https://conductscience.org/library/papers/36586393 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35108564
GET https://conductscience.org/api/papers/v1/35108564/references?page=2